These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35895243)

  • 1. Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
    Yan Z; Li R; Shi W; Yao L
    Metab Brain Dis; 2022 Oct; 37(7):2511-2520. PubMed ID: 35895243
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson's disease: An animal study.
    Yan Z; Yang F; Sun L; Yu J; Sun L; Si Y; Yao L
    Brain Behav Immun; 2022 Nov; 106():307-321. PubMed ID: 36126853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
    Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
    Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
    Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
    Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of gut microbiota and metabolome with Parkinson's disease.
    Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
    Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
    Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPARδ-ligand erucic acid in rotenone-induced Parkinson's disease model in zebrafish.
    Ünal İ; Cansız D; Sürmen MG; Sürmen S; Sezer Z; Beler M; Üstündağ ÜV; Güzel E; Alturfan AA; Emekli-Alturfan E
    Eur J Neurosci; 2023 Feb; 57(4):585-606. PubMed ID: 36564343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal metabolomics profiling of serum amino acids in rotenone-induced Parkinson's mouse model.
    Yan Z; Yang F; Wen S; Ding W; Si Y; Li R; Wang K; Yao L
    Amino Acids; 2022 Jan; 54(1):111-121. PubMed ID: 35028704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
    Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
    Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Nardostachys jatamansi on gut microbiota of rats with Parkinson's disease].
    Wan GH; Wei XJ; Li JY; Yang X; Yu JH; Liu JF; Wang YQ; Lyu Y; Jin ZX; Shi JL
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):499-510. PubMed ID: 35178995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.
    Hong CT; Chan L; Chen KY; Lee HH; Huang LK; Yang YSH; Liu YR; Hu CJ
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of
    Lee YZ; Cheng SH; Chang MY; Lin YF; Wu CC; Tsai YC
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
    Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
    Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.